NASDAQ:TENX

Tenax Therapeutics Stock Insider Trading

etoro logo Buy TENX
*Your capital is at risk
$13.64
+1.39 (+11.35%)
At Close: Jun 23, 2026

Tenax Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 15.35M and sold 4.95M TENX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 15.35M shares
Sell 4.95M shares
96% Buy Activity
Weak Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
May 11, 2026
Buy
Stock Option (right to buy)
A-Award
Staab Thomas R Ii
Chief Financial Officer
C-Suite Officer 450 000
Value: $5.38M
May 11, 2026
Buy
Common Stock
A-Award
Staab Thomas R Ii
Chief Financial Officer
C-Suite Officer 10 000
Value: $119.5K
May 11, 2026
Buy
Common Stock
Staab Thomas R Ii
Chief Financial Officer
C-Suite Officer 0
Value: $0
Jan 30, 2026
Buy
Stock Option (right to buy)
M-Exempt
Mcgauley Thomas
Interim CFO
C-Suite Officer 50 000
Value: $625.5K
Jan 09, 2026
Buy
Stock Option (right to buy)
A-Award
Proehl Gerald T
Director
Director 3 000
Value: $39.9K
Jan 09, 2026
Buy
Stock Option (right to buy)
A-Award
Rich Stuart
Chief Medical Officer
Officer 250 000
Value: $3.33M
Jan 09, 2026
Buy
Stock Option (right to buy)
A-Award
Davidson Michael H.
Director
Director 30 000
Value: $399.0K
Jan 09, 2026
Buy
Stock Option (right to buy)
A-Award
Giordano Christopher Thomas
CEO
CEO / President 450 000
Value: $5.99M
Jan 09, 2026
Buy
Stock Option (right to buy)
A-Award
Almenoff June Sherie
Director
Director 30 000
Value: $399.0K
Jan 09, 2026
Buy
Stock Option (right to buy)
A-Award
Doogan Declan
Director
Director 30 000
Value: $399.0K
Jan 09, 2026
Buy
Stock Option (right to buy)
A-Award
Hunter Robyn
Director
Director 30 000
Value: $399.0K
Dec 09, 2025
Buy
Common Stock
P-Purchase
Rich Stuart
Chief Medical Officer
Officer 2 500
Value: $25.5K
Dec 08, 2025
Buy
Common Stock
P-Purchase
Rich Stuart
Chief Medical Officer
Officer 2 500
Value: $25.3K
Dec 04, 2025
Buy
Common Stock
P-Purchase
Rich Stuart
Chief Medical Officer
Officer 2 500
Value: $23.0K
Dec 03, 2025
Buy
Common Stock
P-Purchase
Rich Stuart
Chief Medical Officer
Officer 1 500
Value: $13.6K
Dec 02, 2025
Buy
Common Stock
P-Purchase
Rich Stuart
Chief Medical Officer
Officer 1 000
Value: $9K
Nov 20, 2025
Buy
Common Stock
P-Purchase
Giordano Christopher Thomas
CEO
CEO / President 538
Value: $4K
Nov 19, 2025
Buy
Common Stock
P-Purchase
Giordano Christopher Thomas
CEO
CEO / President 455
Value: $3K
Nov 18, 2025
Buy
Common Stock
P-Purchase
Giordano Christopher Thomas
CEO
CEO / President 1 612
Value: $12.5K
Nov 18, 2025
Buy
Common Stock
P-Purchase
Almenoff June Sherie
Director
Director 1 900
Value: $14.3K
Nov 17, 2025
Buy
Common Stock
P-Purchase
Almenoff June Sherie
Director
Director 93
Value: $665
Nov 17, 2025
Buy
Common Stock
P-Purchase
Mcgauley Thomas
Interim CFO
C-Suite Officer 2 000
Value: $14.7K
Nov 17, 2025
Buy
Common Stock
P-Purchase
Mcgauley Thomas
Interim CFO
C-Suite Officer 5 000
Value: $36.1K
Nov 17, 2025
Buy
Common Stock
P-Purchase
Mcgauley Thomas
Interim CFO
C-Suite Officer 1 000
Value: $7K
Jul 01, 2025
Buy
Stock Option (right to buy)
A-Award
Almenoff June Sherie
Director
Director 80 000
Value: $460.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT TENAX THERAPEUTICS
Tenax Therapeutics
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertensi...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
OSW
$24.00
17.08% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE